Practical aspects of biological throught levels and antidrug antibodies in rheumatoid arthritis and spondyloarthritis José Rosas; María Martín-López; Teresa Otón; Alejandro Balsa; Jaime Calvo-Alén; Raimon Sanmartí; Jesús Tornero; Loreto Carmona;

Adalimumab treatment of resistant chondrocalcinosis Fatih Tastekin; Kenan Aksu;

Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry José Rosas; José Miguel Senabre-Gallego; Gregorio Santos-Soler; José Antonio Bernal; Ana Pons Bas;